Abbasinejad, MD, reviews factors that may affect the treatment plan, including: Current weight, BMI, and recent weight changes Personal and family medical history Current prescriptions, supplements, and possible interactions Previous weight-loss methods and their outcomes Digestive, pancreatic, gallbladder, kidney, or thyroid concerns Pregnancy, breastfeeding, or plans to become pregnant Eating patterns, physical activity, sleep, and treatment goals Patients should also discuss any history of severe allergic reactions and all symptoms affecting nutrition or hydration
Please visit wegovy.com for more information
In SURMOUNT-1, tirzepatide 15 mg produced 20.9% mean body weight loss at 72 weeks
A clinician will assess factors such as BMI, medical history, and suitability before recommending treatment
Semaglutide shelf life under these conditions has been well documented for branded versions, and compounded versions follow similar patterns when the formulation includes adequate stabilizers
Come in for a professional to see if the Surface Awaken system is right for them